ReviewJournal of clinical medicine2024

Rosuvastatin-Based Lipid-Lowering Therapy for the Control of LDL Cholesterol in Patients at High Vascular Risk.

Jose María Mostaza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.